FSOYF yields 123.46% · JNJ yields 2.13%● Live data
📍 FSOYF pulled ahead of the other in Year 1
Combined, FSOYF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FSOYF + JNJ for your $10,000?
WithSecure Oyj operates in corporate security business worldwide. Its software and services include WithSecure Elements, a cloud based security platform to reduce risk, complexity, and inefficiency; WithSecure Elements Endpoint Protection, a cloud-native AI-powered endpoint protection solution; WithSecure Business Suite for organization's security challenges; WithSecure Elements Endpoint Detection and Response; WithSecure Elements Vulnerability Management, a cloud-based vulnerability scanner that covers network, assets, deep web, and compliance; and WithSecure Elements Collaboration Protection; and WithSecure Cloud Protection for Salesforce. The company also provides consulting services, including security strategy and risk management, resilience development, and security assurance services; professional support services; security training services; and managed services, such as countercept managed detection and response, attack surface management, and cloud security posture management services; USB armory, a smallest secure computer; and Armory Drive, an encrypted storage solution. WithSecure Oyj was founded in 1988 and is headquartered in Helsinki, Finland.
Full FSOYF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.